Log in
Enquire now
‌

US Patent 11359019 Antibodies to LILRB2

Patent 11359019 was granted and assigned to Jounce Therapeutics, Inc. on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Currently, there are no issues on this topic.

Find more entities like US Patent 11359019 Antibodies to LILRB2

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.